All roads lead to PP 2A: exploiting the therapeutic potential of this phosphatase

Cites (214)

Items 201–214 of 214

1. Alterations of tumour suppressor gene PPP2R1B in hepatocellular carcinoma
   Huei-Chi Chou, Chien‐Hung Chen, Mei–Hsuan Lee, Cha‐Ze Lee, Guan‐Tarn Huang, Pei‐Ming Yang, Po‐Huang Lee, Jin‐Chuan Sheu · 2007 · Cancer Letters
2. Recent Natural Selection Identifies a Genetic Variant in a Regulatory Subunit of Protein Phosphatase 2A that Associates with Altered Cancer Risk and Survival
   Lukasz F. Grochola, Alexei Vázquez, Elisabeth E. Bond, Peter Würl, Helge W. Taubert, Thomas H. Müller, Arnold J. Levine, Gareth L. Bond · 2009 · Clinical Cancer Research
3. CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion
   Mo Zhai, Lin Cong, Yaxin Han, Guanjun Tu · 2013 · Tumor Biology
4. Phosphorylation of SET Protein at Ser171 by Protein Kinase D2 Diminishes Its Inhibitory Effect on Protein Phosphatase 2A
   Atsushi Irie, Kumiko Harada, Norie Araki, Yasuharu Nishimura · 2012 · PLoS ONE
5. Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation
   Cuicui Yang, Xue-xian Kuai, Yali Li, Li Zhang, Jianchun Yu, Lin Li, Lan Zhang · 2013 · Evidence-based Complementary and Alternative Medicine
6. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
   Denise Godenèche, Marie-Josée Rapp, Alain Roger Thierry, Françoise Laval, Jean‐Claude Madelmont, Philippe J. M. Chollet, Annie Veyre · 1990 · PubMed
7. Identification of porcine reproductive and respiratory syndrome virus inhibitors through an oriented screening on natural products
   Wengui Li, Feiyan Dai, Yong‐Xian Cheng, Gefen Yin, Junlong Bi, Dian-peng Li · 2013 · Chemical Research in Chinese Universities
8. Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma
   Ie‐Ming Shih, Tian‐Li Wang · 2011 · The Journal of Pathology
9. A Novel SET Antagonist (OP449) Is Cytotoxic to CML Cells, Including the Highly-Resistant BCR-ABLT315I Mutant, and Demonstrates Enhanced Efficacy in Combination with ABL Tyrosine Kinase Inhibitors,
   Anupriya Agarwal, Ryan J. MacKenzie, Jessica Oddo, Michael Peter Vitek, Dale J. Christensen, Brian J. Druker · 2011 · Blood
10. CIP2A expression and prognostic role in patients with esophageal adenocarcinoma
    Tuomo K Rantanen, Tuuli Kauttu, Jonne Åkerla, Teemu Honkanen, Leena Anneli Krogerus, Jarmo Salo, Timo Paavonen, Niku Oksala · 2013 · Medical Oncology
11. A LCMT1-PME-1 methylation equilibrium controls mitotic spindle size
    Xiaoyu Xia, Ankur A. Gholkar, Silvia Senese, Jorge Z. Torres · 2015 · Cell Cycle
12. Molecular modeling of the catalytic domain of serine/threonine phosphatase-1 with the Zn2+ and Mn2+ di-nuclear ion centers in the active site
    Edyta Woźniak, Stanisław Ołdziej, Jerzy Ciarkowski · 2000 · Computers & Chemistry
13. Identification of Porcine Reproductive and Respiratory Syndrome Virus Inhibitors Through an Oriented Screening on Natural Products
    Li, Wengui, Dai, Fei-yan, Cheng, Yong-xian, Yin Yin, Ge-fen, Guoan Bi, Jun-long et al. · 2013 · Acta Scientiarum Naturalium Universitatis Sunyatseni
14. Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD + Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496
    Ranjana H. Advani, Fangxin Hong, Leo I. Gordon, Randy D. Gascoyne, Henry Wagner, Richard T. Hoppe, Richard I. Fisher, Nancy L. Bartlett, Brad S. Kahl, Patrick J. Stiff et al. · 2011 · Blood